Suketu Upadhyay

Non Executive / Other Non-Executive
  • Director Verified:
  • No
Login/ Register  to follow report
Company:

About

Mr. Upadhyay joined our Board in 2022. He is currently the Executive Vice President and Chief Financial Officer of Zimmer Biomet, a leading global innovator and manufacturer of orthopedic solutions, a position he has held since July 2019. Prior to joining Zimmer Biomet, Mr. Upadhyay served as Senior Vice President, Global Financial Operations, at Bristol Myers Squibb (BMS) from November 2016 until June 2019, where he was responsible for strategic and operational initiatives across BMS’s supply chain, commercial operations, R&D and business development. Prior to that, he served as Executive Vice President and Chief Financial Officer of Endo International and as an executive in various global finance and strategy leadership roles at BD (Becton, Dickinson and Company) including Interim Chief Financial Officer, Chief Accounting Officer and CFO of International. In addition, Mr. Upadhyay has also held several global finance and strategy roles at AstraZeneca and Johnson & Johnson, including R&D, supply chain, commercial operations and business development. Mr. Upadhyay spent the early part of his career in public accounting with KPMG, earning his CPA and CMA designations. He also currently serves as a member of the board of directors for CSC (Corporate Services Company), a privately held business solutions company. Mr. Upadhyay holds a Bachelor of Science in finance from Albright College and an M.B.A. from The Fuqua School of Business at Duke University.

 

Personal Details

Title: Mr
Surname: Upadhyay
DoB: 01/01/1969
Age: 57 years
M/F: Male
Nationality: American
Country of Birth: United States of America
Language: English
Qualification: BFin, MBA, CPA
Industry:

 

Qualifications & Experience

 

Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:

 

Other directorships (state)

(only entities turnover at least $5m p/a)

CompanyCommitteePositionDate Appointed
BoardChief Financial Officer01/07/2019
BoardMember

 

Working history

Name

Other Official

Bristol Myers Squibb
Appointed Date: 01/11/2016
Date Resigned:
Industry: Pharmaceutical

View Company

Name

Chief Financial Officer

Becton Dickinson
Appointed Date:
Date Resigned:
Industry: Healthcare

View Company

Name

Member

AstraZeneca PLC
Appointed Date:
Date Resigned:
Industry: Pharmaceutical

View Company

Name

Member

Johnson and Johnson
Appointed Date:
Date Resigned:
Industry: Healthcare

View Company

 

Committee/s

CompanyCommitteeRoleAppointment DateResignation Date
Vertex PharmaceuticalsBoardMember01/01/2022
Vertex PharmaceuticalsAuditChairperson01/01/2022

 

Independence Questions

Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.
Download PDF